Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. - Wikidata - awgldk - TriplyDB

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.

http://www.wikidata.org/entity/Q37262617

about

ABO blood group and incidence of epithelial ovarian cancer Metabolic consequences of modern immunosuppressive agents in solid organ transplantation Epicardial Fat: Physiological, Pathological, and Therapeutic Implications Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?New obesity classification criteria as a tool for bariatric surgery indication Role of adiponectin and some other factors linking type 2 diabetes mellitus and obesity Obstructive sleep apnea as a risk factor for type 2 diabetes mellitus Vascular repair strategies in type 2 diabetes: novel insights Effect of alcohol on adipose tissue: a review on ethanol mediated adipose tissue injury Inflammation and metabolic dysfunction: links to cardiovascular diseases PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty Adipose tissue dysfunction in nascent metabolic syndrome Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug Regulation of vascular tone by adipocytes.Effect of cardiac rehabilitation on metabolic syndrome and its components: A systematic review and meta-analysis Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies Literature mining for the discovery of hidden connections between drugs, genes and diseases Adipose tissue deletion of Gpr116 impairs insulin sensitivity through modulation of adipose function Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes Acetylshikonin from Zicao Prevents Obesity in Rats on a High-Fat Diet by Inhibiting Lipid Accumulation and Inducing Lipolysis Renal outcomes of bariatric surgery in obese adults with diabetic kidney disease.Insulin Signaling and Heart Failure.Antiobesity Effects of an Edible Halophyte Nitraria retusa Forssk in 3T3-L1 Preadipocyte Differentiation and in C57B6J/L Mice Fed a High Fat Diet-Induced Obesity.Assessment of endothelial dysfunction in childhood obesity and clinical use.Association of serum angiopoietin-like protein 2 with carotid intima-media thickness in subjects with type 2 diabetes Obesity, high-molecular-weight (HMW) adiponectin, and metabolic risk factors: prevalence and gender-specific associations in Estonia.The oxidative modification of von Willebrand factor is associated with thrombotic angiopathies in diabetes mellitus Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both Pediatric Metabolic Syndrome: Pathophysiology and Laboratory Assessment Spatiotemporal regulation of early lipolytic signaling in adipocytes.Molecular approaches in obesity studies Regulation of Microvascular Function by Adipose Tissue in Obesity and Type 2 Diabetes: Evidence of an Adipose-Vascular Loop.Effects of Ang II receptor blocker irbesartan on adipose tissue function in mice with metabolic disorders Association of vaspin with metabolic syndrome: the pivotal role of insulin resistance Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes.Arterial and fat tissue inflammation are highly correlated: a prospective 18F-FDG PET/CT study.Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk prevention Co-expressed immune and metabolic genes in visceral and subcutaneous adipose tissue from severely obese individuals are associated with plasma HDL and glucose levels: a microarray study.Repeated sense of hunger leads to the development of visceral obesity and metabolic syndrome in a mouse model -94 ATTG insertion/deletion polymorphism of the NFKB1 gene is associated with coronary artery disease in Han and Uygur women in China.

P2860

Q24599521-4FE24178-9555-453B-AE65-922EB1F9F817 Q26746936-6C97D37D-AE22-441E-8CFE-0E894C351103 Q26746996-03B57BB9-2AFA-415A-B816-6714313A8BCD Q26749088-251BBA1C-E659-4582-8234-9CE38D3A2DED Q26774656-FA8A215D-393F-495D-8030-BEB183E4E669 Q26777653-831C4FF2-9957-49D2-A104-FC7829497B8D Q26778430-CDBA3ECF-14D4-4122-89AA-F26A6CF403F4 Q26778658-A7A7224C-178D-4D43-B043-90C84E1ABDCE Q26785565-5E78E1C1-452B-4DF5-AE2D-3545EB6B16C0 Q26851186-5E385A24-4527-419F-A8BD-60C82581FB62 Q27024799-8BDAED43-0F84-4497-B3FD-F11BE249D11F Q27026065-D55355CF-552E-44B8-8DE4-BC87CE8086F0 Q27301094-149E8DF7-F7EC-4D93-9CA1-D1A150F99A3A Q27691400-3949A4F4-4371-4520-AB2B-AF0303EE7B40 Q28069972-55EAD1E0-984D-40D6-AFF4-9F710FC3B692 Q28088325-6725A6C1-C3C3-429E-AF3D-0E68963F0EE7 Q28475561-0A18133E-7A88-427C-B921-88D5ACFF3080 Q28505920-1024967D-ED64-42C1-93F6-AC4892A5EFEB Q28546703-B24425CD-9E68-4F1F-BE28-424C7A394F85 Q28552550-3D996C99-DEAD-4E0A-8F0A-8ABEC4346B3A Q30360386-EEB3D6C3-85E4-446D-AEA8-8E42C79E00C5 Q30377910-542B4644-DD45-499C-B4D2-505011E28DA5 Q30392630-9D1AAD9F-3998-405E-8964-06B040C2CCE1 Q30430798-C83385EA-C8B1-47ED-B38F-05595199DE2B Q30641972-3973CFF1-4CB8-445B-AEBA-4E971FC12C1F Q31138460-092AF982-83A1-4706-87DA-3D5BDE1EAD34 Q33405692-790860BE-2D16-4DF5-876D-D43B08A8E0C1 Q33455659-01D7B59D-BF14-46AA-86F3-1E9DAC780888 Q33551642-21E868B2-2BA7-419E-9F3F-A4C6FE338F14 Q33553850-A8BB6F38-EE2B-41E5-81D7-0039DF5BD48D Q33596708-D4B124C1-67F5-45FF-AD99-6027B7DB016C Q33602767-B39AF65B-A5BD-4D6D-A1D3-BDFBBFDDE5B1 Q33611545-9FA6A5C0-D947-48C8-AD31-AC61933C4333 Q33612532-A264F93C-9109-44FE-AF03-BB40DE5E805C Q33623899-309967BF-CD16-4DA4-A1CB-F9069EE537AC Q33624371-5417353D-EAA5-4CE3-8474-83AD5BB99E54 Q33627732-1E86714E-EAB9-4CFD-811E-289165DC60C6 Q33650368-9D3DE873-46CA-4C9C-A3D3-63AE43E7E1BB Q33690123-E29149E6-783A-412E-8F90-4C709E192595 Q33705966-BEEA0CE6-42C3-466F-B70A-F080AF686D81

P2860

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.

http://www.wikidata.org/entity/Q37262617

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.

@en

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.

@nl

type

label

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.

@en

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.

@nl

prefLabel

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.

@en

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.

@nl

P1433

Q37262617-B6FB6FD2-44A0-4586-87C2-A9FA6926849E

P1476

Q37262617-A0F38E14-7965-45C5-973A-3F28C6C89E5B

P2093

Q37262617-78551221-5A54-49DB-8DF0-DCF7A21D84EB

Q37262617-A46D0A15-148C-4E57-B512-3E53F98E2469

Q37262617-AB8DE036-1086-4D94-BCC4-8C31316858A0

P2860

Q37262617-0490C1C0-FA71-46F8-BC68-9523D244CCE7

Q37262617-05F7027B-4CDD-4A4E-95FC-3A5F615608BE

Q37262617-06608915-B94C-43C6-8065-352AB35A6C9D

Q37262617-0A374F5F-D644-4E42-8202-03730F43B14D

Q37262617-0BAB85BD-CC7C-40F3-9177-4A57F051F510

Q37262617-0EE53EDC-45A8-46F8-A345-0B4A81C42FE5

Q37262617-13765D08-0D47-4377-8E31-610A0E4588F4

Q37262617-13FF73BE-4C2F-46E3-8501-61273DE5B0A9

Q37262617-1A27C8DF-7B50-467B-ADE4-93BC5F29DDB8

Q37262617-24030238-D28C-4E54-8A6A-631F6B9729A1

P304

Q37262617-C0F34B17-7C0D-4472-B942-C4416C544C25

P31

Q37262617-63df514b-e41e-4d46-973b-8131931b5318

Q37262617-BFD3D1C7-1BAA-4A25-A3AC-A9C1068F6B02

P356

Q37262617-9CBEF4E0-AD86-491E-9587-32B3656BB2C8

P433

Q37262617-C1B11C4C-E1C7-43F8-8394-9FA83911DAE2

P478

Q37262617-D83B9095-4A84-430F-B3DE-4F195DCE38F3

P577

Q37262617-7A4CE3A4-AF9E-43B8-BC49-FCF9414F5A74

P5875

Q37262617-E9169846-2D92-428D-97A9-B17F64603675

P698

Q37262617-D6F4F26C-F87F-4787-90FA-205D6CFC12D7

P921

Q37262617-556BA651-E911-43A7-A08D-85C6E85BEDDE

P356

P1433

European Heart Journal

P1476

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.

@en

P2093

Frank L J Visseren

http://www.w3.org/2001/XMLSchema#string

Gideon R Hajer

http://www.w3.org/2001/XMLSchema#string

Timon W van Haeften

http://www.w3.org/2001/XMLSchema#string

P2860

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

Atherosclerosis — An Inflammatory Disease

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

Mechanism of action of fibrates on lipid and lipoprotein metabolism

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation

A novel serum protein similar to C1q, produced exclusively in adipocytes

Monocyte and macrophage heterogeneity

P304

2959-2971

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHN387

http://www.w3.org/2001/XMLSchema#string

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23241890

http://www.w3.org/2001/XMLSchema#string

P698

18775919

http://www.w3.org/2001/XMLSchema#string

P921